Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 24, No 15 (May 20), 2006: pp. 2245-2251
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.04.8033

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toh, C.-K.
Right arrow Articles by Tan, E.-H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Toh, C.-K.
Right arrow Articles by Tan, E.-H.
Related Articles
Right arrowRelated Correspondence

Never-Smokers With Lung Cancer: Epidemiologic Evidence of a Distinct Disease Entity

Chee-Keong Toh, Fei Gao, Wan-Teck Lim, Swan-Swan Leong, Kam-Weng Fong, Swee-Peng Yap, Anne A.L. Hsu, Philip Eng, Heng-Nung Koong, Agasthian Thirugnanam, Eng-Huat Tan

From the Department of Medical Oncology; Division of Clinical Trials and Epidemiological Sciences; Department of Therapeutic Radiology; Department of Surgical Oncology, National Cancer Centre; and the Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore, Singapore.

Address reprint requests to Chee-Keong Toh, MD, Department of Medical Oncology, National Cancer Centre, 11 Hospital Dr, Singapore, Singapore 169610; e-mail: dmotck{at}nccs.com.sg

PURPOSE: Tobacco smoke is a definite causative agent for lung cancer. It is increasingly being recognized that never-smokers can be afflicted with non–small-cell lung cancer (NSCLC). We aim to assess survival differences between smokers and never-smokers with NSCLC.

PATIENTS AND METHODS: We analyzed 975 NSCLC patients who presented from January 1999 to December 2002. Clinical characteristics among current-, former- and never-smokers were tested using {chi}2 or Kruskal-Wallis test. The hazard ratio (HR) for death and its 95% CI were calculated by Cox regression.

RESULTS: Of 975 patients, 59 had no smoking history and 33 had no quit time recorded. Of 883 patients analyzed, 286 patients (32.4%) were never-smokers. One hundred ninety-six never-smokers (68.5%) were females compared with 12% among current- and 13% among former-smokers (P < .001). There was a significant difference in histologic subtype between never-smokers and smokers: 69.9% with adenocarcinoma versus 39.9% (current-smokers) versus 47.3% (former-smokers); 5.9% with squamous cell carcinoma versus 35.7% (current-smokers) versus 28% (former-smokers; P < .001). Smokers had significantly poorer performance status (P = .002) and higher median age at diagnosis (P < .001) while more never-smokers presented with advanced disease (P = .002). Eight hundred and five patients (82.6%) died by May 30, 2005. The HR for smokers was significantly higher on both univariate and multivariate analysis (HR, 1.297; 95% CI, 1.040 to 1.619).

CONCLUSION: Never-smokers comprised a high proportion of NSCLC patients in Singapore. Definite epidemiologic differences exist between never-smokers and smokers. Differences in survival outcome further suggest that the biology underlying the pathogenesis and behavior of the disease may be different for never-smokers.

Presented in part at the 11th World Conference on Lung Cancer, Barcelona, Spain, July 3-6, 2005.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Related Correspondence

  • Effects of Comorbidity and Smoking on the Survival of Lung Cancer Patients
    Jeong-Seon Ryu and Hun-Jae Lee
    JCO 2006 24: 5468-5469 [Full Text]


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
I. I. Na, B. H. Byun, H. J. Kang, G. J. Cheon, J. S. Koh, C. H. Kim, D. H. Choe, B.-Y. Ryoo, J. C. Lee, S. M. Lim, et al.
18F-Fluoro-2-Deoxy-Glucose Uptake Predicts Clinical Outcome in Patients with Gefitinib-Treated Non-Small Cell Lung Cancer
Clin. Cancer Res., April 1, 2008; 14(7): 2036 - 2041.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
F. Ciardiello and G. Tortora
EGFR Antagonists in Cancer Treatment
N. Engl. J. Med., March 13, 2008; 358(11): 1160 - 1174.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
C.-K. Toh and W.-T. Lim
Lung cancer in never-smokers
J. Clin. Pathol., April 1, 2007; 60(4): 337 - 340.
[Full Text] [PDF]


Home page
JCOHome page
J. Subramanian and R. Govindan
Lung Cancer in Never Smokers: A Review
J. Clin. Oncol., February 10, 2007; 25(5): 561 - 570.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J.-S. Ryu and H.-J. Lee
Effects of Comorbidity and Smoking on the Survival of Lung Cancer Patients
J. Clin. Oncol., December 1, 2006; 24(34): 5468 - 5469.
[Full Text] [PDF]


Home page
JCOHome page
C.-K. Toh, W.-T. Lim, S.-S. Leong, and E.-H. Tan
In Reply
J. Clin. Oncol., December 1, 2006; 24(34): 5469 - 5469.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Nagle, C. J. Bain, and P. M. Webb
Cigarette Smoking and Survival after Ovarian Cancer Diagnosis
Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2557 - 2560.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online